Copyright Reports & Markets. All rights reserved.

Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Molecular Diagnostics
    • 1.2.3 Blood Tests
    • 1.2.4 Urinalysis
  • 1.3 Market by Application
    • 1.3.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Urinary Tract Infections
    • 1.3.3 Pneumonia
    • 1.3.4 Surgical Site Infections
    • 1.3.5 Bloodstream Infections
    • 1.3.6 Other Hospital Infections
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Perspective (2016-2027)
  • 2.2 Hospital-Acquired Infection (HAI) Diagnostic Growth Trends by Regions
    • 2.2.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Hospital-Acquired Infection (HAI) Diagnostic Historic Market Share by Regions (2016-2021)
    • 2.2.3 Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Regions (2022-2027)
  • 2.3 Hospital-Acquired Infection (HAI) Diagnostic Industry Dynamic
    • 2.3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Trends
    • 2.3.2 Hospital-Acquired Infection (HAI) Diagnostic Market Drivers
    • 2.3.3 Hospital-Acquired Infection (HAI) Diagnostic Market Challenges
    • 2.3.4 Hospital-Acquired Infection (HAI) Diagnostic Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Revenue
    • 3.1.1 Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Revenue (2016-2021)
    • 3.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2016-2021)
  • 3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hospital-Acquired Infection (HAI) Diagnostic Revenue
  • 3.4 Global Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Ratio
    • 3.4.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2020
  • 3.5 Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Area Served
  • 3.6 Key Players Hospital-Acquired Infection (HAI) Diagnostic Product Solution and Service
  • 3.7 Date of Enter into Hospital-Acquired Infection (HAI) Diagnostic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Infection (HAI) Diagnostic Breakdown Data by Type

  • 4.1 Global Hospital-Acquired Infection (HAI) Diagnostic Historic Market Size by Type (2016-2021)
  • 4.2 Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Type (2022-2027)

5 Hospital-Acquired Infection (HAI) Diagnostic Breakdown Data by Application

  • 5.1 Global Hospital-Acquired Infection (HAI) Diagnostic Historic Market Size by Application (2016-2021)
  • 5.2 Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
  • 6.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
    • 6.2.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    • 6.2.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
    • 6.2.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
  • 6.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
    • 6.3.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    • 6.3.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
    • 6.3.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
  • 6.4 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
    • 6.4.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
    • 6.4.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
  • 7.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
    • 7.2.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    • 7.2.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
    • 7.2.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
  • 7.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
    • 7.3.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    • 7.3.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
    • 7.3.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
  • 7.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
    • 7.4.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
    • 7.4.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
  • 8.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
    • 8.2.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
    • 8.3.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region
    • 8.4.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
  • 9.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
    • 9.2.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    • 9.2.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
    • 9.2.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
  • 9.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
    • 9.3.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    • 9.3.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
    • 9.3.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
  • 9.4 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
    • 9.4.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
    • 9.4.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
  • 10.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
    • 10.2.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
    • 10.3.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
    • 10.4.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 bioMérieux
    • 11.1.1 bioMérieux Company Details
    • 11.1.2 bioMérieux Business Overview
    • 11.1.3 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.1.4 bioMérieux Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.1.5 bioMérieux Recent Development
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.2.4 Abbott Laboratories Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.2.5 Abbott Laboratories Recent Development
  • 11.3 Alere, Inc.
    • 11.3.1 Alere, Inc. Company Details
    • 11.3.2 Alere, Inc. Business Overview
    • 11.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.3.4 Alere, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.3.5 Alere, Inc. Recent Development
  • 11.4 Roche
    • 11.4.1 Roche Company Details
    • 11.4.2 Roche Business Overview
    • 11.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.4.4 Roche Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.4.5 Roche Recent Development
  • 11.5 Siemens Healthcare
    • 11.5.1 Siemens Healthcare Company Details
    • 11.5.2 Siemens Healthcare Business Overview
    • 11.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.5.4 Siemens Healthcare Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.5.5 Siemens Healthcare Recent Development
  • 11.6 Becton Dickenson
    • 11.6.1 Becton Dickenson Company Details
    • 11.6.2 Becton Dickenson Business Overview
    • 11.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.6.4 Becton Dickenson Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.6.5 Becton Dickenson Recent Development
  • 11.7 Cepheid Inc.
    • 11.7.1 Cepheid Inc. Company Details
    • 11.7.2 Cepheid Inc. Business Overview
    • 11.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.7.4 Cepheid Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.7.5 Cepheid Inc. Recent Development
  • 11.8 Thermo Fisher Scientific
    • 11.8.1 Thermo Fisher Scientific Company Details
    • 11.8.2 Thermo Fisher Scientific Business Overview
    • 11.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.8.4 Thermo Fisher Scientific Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.8.5 Thermo Fisher Scientific Recent Development
  • 11.9 Seegene, Inc.
    • 11.9.1 Seegene, Inc. Company Details
    • 11.9.2 Seegene, Inc. Business Overview
    • 11.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.9.4 Seegene, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.9.5 Seegene, Inc. Recent Development
  • 11.10 Qiagen
    • 11.10.1 Qiagen Company Details
    • 11.10.2 Qiagen Business Overview
    • 11.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Introduction
    • 11.10.4 Qiagen Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
    • 11.10.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hospital-Acquired Infection (HAI) Diagnostic Scope and Market Size
    Hospital-Acquired Infection (HAI) Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Infection (HAI) Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Molecular Diagnostics
    Blood Tests
    Urinalysis

    Segment by Application
    Urinary Tract Infections
    Pneumonia
    Surgical Site Infections
    Bloodstream Infections
    Other Hospital Infections

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    bioMérieux
    Abbott Laboratories
    Alere, Inc.
    Roche
    Siemens Healthcare
    Becton Dickenson
    Cepheid Inc.
    Thermo Fisher Scientific
    Seegene, Inc.
    Qiagen

    Buy now